FATE
Price
$0.76
Change
+$0.08 (+11.76%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
78.95M
25 days until earnings call
GLUE
Price
$3.95
Change
+$0.06 (+1.54%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
238.66M
33 days until earnings call
Ad is loading...

FATE vs GLUE

Header iconFATE vs GLUE Comparison
Open Charts FATE vs GLUEBanner chart's image
Fate Therapeutics
Price$0.76
Change+$0.08 (+11.76%)
Volume$39.48K
Capitalization78.95M
Monte Rosa Therapeutics
Price$3.95
Change+$0.06 (+1.54%)
Volume$11.81K
Capitalization238.66M
FATE vs GLUE Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. GLUE commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and GLUE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (FATE: $0.68 vs. GLUE: $3.89)
Brand notoriety: FATE and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 107% vs. GLUE: 151%
Market capitalization -- FATE: $78.95M vs. GLUE: $238.66M
FATE [@Biotechnology] is valued at $78.95M. GLUE’s [@Biotechnology] market capitalization is $238.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while GLUE’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • GLUE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FATE is a better buy in the short-term than GLUE.

Price Growth

FATE (@Biotechnology) experienced а -22.87% price change this week, while GLUE (@Biotechnology) price change was -26.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

FATE is expected to report earnings on Apr 30, 2025.

GLUE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($239M) has a higher market cap than FATE($78.9M). GLUE YTD gains are higher at: -43.948 vs. FATE (-58.788). GLUE has higher annual earnings (EBITDA): -72.99M vs. FATE (-176.58M). GLUE has more cash in the bank: 372M vs. FATE (279M). GLUE has less debt than FATE: GLUE (42.7M) vs FATE (85.3M). GLUE has higher revenues than FATE: GLUE (75.6M) vs FATE (13.6M).
FATEGLUEFATE / GLUE
Capitalization78.9M239M33%
EBITDA-176.58M-72.99M242%
Gain YTD-58.788-43.948134%
P/E RatioN/AN/A-
Revenue13.6M75.6M18%
Total Cash279M372M75%
Total Debt85.3M42.7M200%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEGLUE
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
85%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 6 days ago
85%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-11.69%
ALLO - FATE
58%
Loosely correlated
-4.17%
NTLA - FATE
56%
Loosely correlated
-5.62%
CRBU - FATE
53%
Loosely correlated
-8.83%
CRSP - FATE
52%
Loosely correlated
-4.47%
BEAM - FATE
51%
Loosely correlated
-10.93%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with ATXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-11.79%
ATXS - GLUE
42%
Loosely correlated
-6.70%
CRSP - GLUE
41%
Loosely correlated
-4.47%
FATE - GLUE
40%
Loosely correlated
-11.69%
RXRX - GLUE
40%
Loosely correlated
-9.07%
CRBU - GLUE
39%
Loosely correlated
-8.83%
More